Ghent University Academic Bibliography

Your filters: cql: author="Meers, Stef" or (type any "bookEditor issueEditor" and editor="Meers, Stef")

Add to list
- Journal Article
- A1
- open access
Beyond the usual suspects : RSV infection in patients with hematological malignancies compared to influenza and SARS‐COV‐2 : a report from the EPICOVIDEHA/EPIRESEHA registry

Jon Salmanton‐García, Francesco Marchesi, Milan Navrátil, Iker Falces‐Romero, Maria Ilaria Del Principe, Jorge Labrador, Klára Piukovics, Verena Petzer, Monika M. Biernat, Michail Samarkos, et al.

(2026) AMERICAN JOURNAL OF HEMATOLOGY. 101(2). p.365-375
Add to list
- Journal Article
- A1
- open access
Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic : results from the epicovideha registry

Pellegrino Musto, Jon Salmanton‐García, Nicola Sgherza, Rui Bergantim, Francesca Farina, Andreas Glenthøj, Guldane Cengiz Seval, Barbora Weinbergerová, Valentina Bonuomo, Yavuz M. Bilgin, et al.

(2024) HEMATOLOGICAL ONCOLOGY. 42(1).
Add to list
- Journal Article
- A1
- open access
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients : results from the EPICOVIDEHA registry

Tommaso Francesco Aiello, Jon Salmanton-Garcia, Francesco Marchesi, Barbora Weinbergerova, Andreas Glenthoj, Jens Van Praet (UGent) , Francesca Farina, Julio Davila-Valls, Sonia Martin-Perez, Shaimaa El-Ashwah, et al.

(2024) HAEMATOLOGICA. 109(8). p.2693-2700
Add to list
- Journal Article
- A1
- open access
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies : results from the EPICOVIDEHA survey

Tobias Lahmer, Jon Salmanton-García, Francesco Marchesi, Shaimaa El-Ashwah, Marcio Nucci, Caroline Besson, Federico Itri, Ozren Jaksic, Natasha Čolović, Barbora Weinbergerová, et al.

(2024) INFECTION. 52(3). p.1125-1141
Add to list
- Journal Article
- A1
- open access
Decoding the historical tale : COVID-19 impact on haematological malignancy patients : EPICOVIDEHA insights from 2020 to 2022

Jon Salmanton-García, Francesco Marchesi, Francesca Farina, Barbora Weinbergerová, Federico Itri, Julio Dávila-Valls, Sonia Martín-Pérez, Andreas Glenthøj, Ditte Stampe Hersby, Maria Gomes Da Silva, et al.

(2024) ECLINICALMEDICINE. 71.
Add to list
- Journal Article
- A1
- open access
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe : a matched-paired analysis from the EPICOVIDEHA registry

Jon Salmanton-García, Francesco Marchesi, Philipp Koehler, Barbora Weinbergerová, Natasa Čolović, Iker Falces-Romero, Caterina Buquicchio, Francesca Farina, Jens Van Praet (UGent) , Monika M. Biernat, et al.

(2023) INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 62(4).
Add to list
- Journal Article
- A1
- open access
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies : a report from the EPICOVIDEHA registry

Jon Salmanton-García, Francesco Marchesi, Maria Gomes da Silva, Francesca Farina, Julio Dávila-Valls, Yavuz M. Bilgin, Andreas Glenthøj, Iker Falces-Romero, Jaap Van Doesum, Jorge Labrador, et al.

(2023) ECLINICALMEDICINE. 58.
Add to list
- Journal Article
- A1
- open access
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients : EPICOVIDEHA findings

Giuseppe Rossi, Jon Salmanton-García, Chiara Cattaneo, Francesco Marchesi, Julio Dávila-Valls, Sonia Martín-Pérez, Federico Itri, Alberto López-García, Andreas Glenthøj, Maria Gomes da Silva, et al.

(2023) INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 137. p.98-110
Add to list
- Journal Article
- A2
- open access
Effectiveness and safety of ibrutinib for chronic lymphocytic leukemia in routine clinical practice : 3-year follow-up of the Belgian Ibrutinib Real-World Data (BiRD) study

Ann Janssens, Zwi N. Berneman, Fritz Offner (UGent) , Sylvia Snauwaert, Philippe Mineur, Gaetan Vanstraelen, Stef Meers, Isabelle Spoormans, Dominique Bron, Isabelle Vande Broek, et al.

(2022) CLINICAL HEMATOLOGY INTERNATIONAL. 4(4). p.133-143
Add to list
- Journal Article
- A1
- open access
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection : a European Hematology Association Survey (EPICOVIDEHA)

Maria Stefania Infante, Jon Salmanton-García, Ana Fernández-Cruz, Francesco Marchesi, Ozren Jaksic, Barbora Weinbergerová, Caroline Besson, Rafael F. Duarte, Federico Itri, Toni Valković, et al.

(2022) FRONTIERS IN ONCOLOGY. 12.

Academic Bibliography

Beyond the usual suspects : RSV infection in patients with hematological malignancies compared to influenza and SARS‐COV‐2 : a report from the EPICOVIDEHA/EPIRESEHA registry

Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic : results from the epicovideha registry

Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients : results from the EPICOVIDEHA registry

Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies : results from the EPICOVIDEHA survey

Decoding the historical tale : COVID-19 impact on haematological malignancy patients : EPICOVIDEHA insights from 2020 to 2022

Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe : a matched-paired analysis from the EPICOVIDEHA registry

Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies : a report from the EPICOVIDEHA registry

Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients : EPICOVIDEHA findings

Effectiveness and safety of ibrutinib for chronic lymphocytic leukemia in routine clinical practice : 3-year follow-up of the Belgian Ibrutinib Real-World Data (BiRD) study

B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection : a European Hematology Association Survey (EPICOVIDEHA)

Contents

Support

Contact